HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)
Status:
Completed
Trial end date:
2019-02-18
Target enrollment:
Participant gender:
Summary
This is a single arm multicenter pilot study to provide preliminary evidence whether
sofosbuvir (SOF) is efficacious and can be safely used in patients with chronic Hepatitis E
virus infection.
Phase:
Phase 2
Details
Lead Sponsor:
Hannover Medical School
Collaborators:
German Center for Infection Research Gilead Sciences HepNet Study House, German Liverfoundation